$AUTL

$2.15▲ +2.4% YTD

2 SEC 13D/G filings tracked · Last updated Sep 9, 2026

Filing History

CP $2.15▲ +2.4%Sep 9, 2026 · ThinkSabio Blog

$AUTL - Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis…

SEC 13D/G

AUTL - Autolus Therapeutics plc - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$2.08▲ 10.05%Aug 14, 2026 · ThinkSabio Blog

$AUTL SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #AUTL Autolus Therapeutics plc : $2.08 Sector: Healthcare | YTD:…